BSE Live
Jan 29, 16:01Prev. Close
1224.30
Open Price
1216.00
Bid Price (Qty.)
1208.45 (4)
Offer Price (Qty.)
1209.65 (464)
NSE Live
Jan 29, 15:59Prev. Close
1222.50
Open Price
1215.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1208.90 (4)
| Balance Sheet of Dr Reddys Laboratories (in Rs. Cr.) | Mar 05 | |
| 12 mths | ||
| EQUITIES AND LIABILITIES | ||
| SHAREHOLDER'S FUNDS | ||
| Equity Share Capital | 38.26 | |
| Total Share Capital | 38.26 | |
| Reserves and Surplus | 1,903.52 | |
| Total Reserves and Surplus | 1,903.52 | |
| Total Shareholders Funds | 1,941.78 | |
| Minority Interest | 0.00 | |
| NON-CURRENT LIABILITIES | ||
| Long Term Borrowings | 17.78 | |
| Deferred Tax Liabilities [Net] | 21.82 | |
| Other Long Term Liabilities | 0.00 | |
| Long Term Provisions | 0.00 | |
| Total Non-Current Liabilities | 39.60 | |
| CURRENT LIABILITIES | ||
| Short Term Borrowings | 262.64 | |
| Trade Payables | 475.00 | |
| Other Current Liabilities | 19.75 | |
| Short Term Provisions | 185.54 | |
| Total Current Liabilities | 942.92 | |
| Total Capital And Liabilities | 2,924.30 | |
| ASSETS | ||
| NON-CURRENT ASSETS | ||
| Tangible Assets | 600.29 | |
| Intangible Assets | 179.60 | |
| Capital Work-In-Progress | 61.60 | |
| Fixed Assets | 841.50 | |
| Non-Current Investments | 131.97 | |
| Deferred Tax Assets [Net] | 0.96 | |
| Long Term Loans And Advances | 0.00 | |
| Other Non-Current Assets | 0.00 | |
| Total Non-Current Assets | 974.43 | |
| CURRENT ASSETS | ||
| Current Investments | 0.00 | |
| Inventories | 352.69 | |
| Trade Receivables | 382.12 | |
| Cash And Cash Equivalents | 935.50 | |
| Short Term Loans And Advances | 279.57 | |
| OtherCurrentAssets | 0.00 | |
| Total Current Assets | 1,949.87 | |
| Total Assets | 2,924.30 | |
| OTHER ADDITIONAL INFORMATION | ||
| CONTINGENT LIABILITIES, COMMITMENTS | ||
| Contingent Liabilities | 197.85 | |
| BONUS DETAILS | ||
| Bonus Equity Share Capital | 17.49 | |
| NON-CURRENT INVESTMENTS | ||
| Non-Current Investments Quoted Market Value | 0.79 | |
| Non-Current Investments Unquoted Book Value | 0.00 | |
| CURRENT INVESTMENTS | ||
| Current Investments Quoted Market Value | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 |
22.01.2026
Dr Reddys Labs Consolidated December 2025 Net Sales at Rs 8,753.40 crore, up 4.44% Y-o-Y
22.01.2026
Dr Reddys Labs Standalone December 2025 Net Sales at Rs 4,282.70 crore, down 14.6% Y-o-Y
22.01.2026
16.01.2026
22.01.2026
Dr Reddys Labs Consolidated December 2025 Net Sales at Rs 8,753.40 crore, up 4.44% Y-o-Y
22.01.2026
Dr Reddys Labs Standalone December 2025 Net Sales at Rs 4,282.70 crore, down 14.6% Y-o-Y
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
28.10.2025
Dr Reddys Labs Consolidated September 2025 Net Sales at Rs 8,828.30 crore, up 9.83% Y-o-Y
22.01.2025
Dr Reddy's Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth
12.07.2023
Dr Reddys Laboratories Q1 PAT seen up 73.7% YoY to Rs 912.4 cr: Nirmal Bang
24.01.2023
Dr Reddy’s Q3 Preview | Sharp drop in net profit likely on slump in US revenues
27.10.2022
Dr Reddy’s Q2 preview: Pharma major likely to report sharp drop in net profit on weak US biz